Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
Go back to Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will DiscontinueMerck & Co. (NYSE: MRK) | Delayed: 130.72 +3.72 (2.93%) | |||||
---|---|---|---|---|---|---|
Previous Close | $127.00 | 52 Week High | $65.46 | |||
Open | $129.69 | 52 Week Low | $47.97 | |||
Day High | $132.80 | P/E | 88.93 | |||
Day Low | $128.76 | EPS | $1.47 | |||
Volume | 12,755,225 |